News Viral Safety Expert, Audrey Brussel, joins PathoQuest Pour la version en français de ce communiqué de presse : cliquez ici Audrey Brussel brings her industrial expertise to support the development of added-value services for the quality control of biologics...
News PathoQuest Announces Appointment of Laurent Lafferrere as Chief Operating Officer PARIS, FRANCE, April 27, 2020 – PathoQuest,a leading genomic expert in clinical diagnostics and biologics testing applications with innovative next-generation sequencing (NGS)...
Other Transgene chooses PathoQuest innovative NGS-based safety release test for TG4050 phase I clinical trial targeting patients with head-neck and ovarian cancers and for Invir.IO™ a platform for recombinant viral vector manufacturing. Return to the list of...
Press Release PathoQuest CEO Jean-François Brepson discusses “NGS and New Frontiers in Infectious Disease” during new Illumina Genomics podcast In a new Illumina Genomics Podcast (Episode 53), Jean-François Brepson discusses the company’s vision of the impact of NGS...
Press Release PathoQuest named 32nd most inventive start-up in France 100brevets.tech – Inventors of the French Tech Awards – has ranked PathoQuest as the 32nd most inventive start-up based in France and the 7th ranked MedTech company. See the list as reported...
Press Release PathoQuest joins MabDesign PathoQuest is now a member of MabDesign, a membership organization dedicated to the creation of a unique environment that allows the economic development and growth of the French industrial sector in the field of therapeutic...